UA115348C2 - Композиція для попередження інфекції mycoplasma spp. - Google Patents

Композиція для попередження інфекції mycoplasma spp.

Info

Publication number
UA115348C2
UA115348C2 UAA201508540A UAA201508540A UA115348C2 UA 115348 C2 UA115348 C2 UA 115348C2 UA A201508540 A UAA201508540 A UA A201508540A UA A201508540 A UAA201508540 A UA A201508540A UA 115348 C2 UA115348 C2 UA 115348C2
Authority
UA
Ukraine
Prior art keywords
mycoplasma spp
subunit vaccine
infection
prevention
relates
Prior art date
Application number
UAA201508540A
Other languages
English (en)
Inventor
Цзюнь-Хун Лінь
Чжи-Пен Ван
Мін-Вей Се
Цзен-Вен Чень
Чіень-Юй Фан
Сюе-Тао Лю
Пін-Чен Ян
Original Assignee
Агрікалчерал Текнолоджи Рісьоч Інстітьют
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to UAA201707071A priority Critical patent/UA116431C2/uk
Application filed by Агрікалчерал Текнолоджи Рісьоч Інстітьют filed Critical Агрікалчерал Текнолоджи Рісьоч Інстітьют
Publication of UA115348C2 publication Critical patent/UA115348C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Винахід стосується композицій для попередження інфекції Mycoplasma spp., що містить білок Mhp145 та фармацевтично прийнятий ад’ювант. Винахід також належить до вектора експресії для попередження інфекції Mycoplasma spp., що містить плазміду, яка містить нуклеотидну послідовність, ген, що кодує партнера для злиття, який являє собою MsyB E. coli, та регуляторний елемент.
UAA201508540A 2013-02-05 2013-05-02 Композиція для попередження інфекції mycoplasma spp. UA115348C2 (uk)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201707071A UA116431C2 (uk) 2013-02-05 2013-02-05 Композиція для попередження інфекції mycoplasma spp.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/071379 WO2014121433A1 (zh) 2013-02-05 2013-02-05 抗霉浆菌的亚单位疫苗

Publications (1)

Publication Number Publication Date
UA115348C2 true UA115348C2 (uk) 2017-10-25

Family

ID=51299148

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201707071A UA116431C2 (uk) 2013-02-05 2013-02-05 Композиція для попередження інфекції mycoplasma spp.
UAA201508540A UA115348C2 (uk) 2013-02-05 2013-05-02 Композиція для попередження інфекції mycoplasma spp.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201707071A UA116431C2 (uk) 2013-02-05 2013-02-05 Композиція для попередження інфекції mycoplasma spp.

Country Status (14)

Country Link
US (7) US9561267B2 (uk)
EP (3) EP2955192B1 (uk)
JP (1) JP6113306B2 (uk)
KR (7) KR101775435B1 (uk)
CN (1) CN104918953B (uk)
BR (1) BR112015018444A2 (uk)
DK (1) DK2955192T3 (uk)
ES (1) ES2812552T3 (uk)
MX (2) MX355078B (uk)
PH (1) PH12015501716A1 (uk)
RU (1) RU2636459C2 (uk)
TW (1) TWI609878B (uk)
UA (2) UA116431C2 (uk)
WO (1) WO2014121433A1 (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101842081B1 (ko) * 2013-11-21 2018-03-26 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 마이코플라즈마 에스피피 감염을 예방하기 위한 조성물
EP3166617B1 (en) * 2014-07-07 2024-01-10 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
CN106139137A (zh) * 2015-03-30 2016-11-23 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
WO2017011919A1 (en) * 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
RU2701816C1 (ru) * 2015-12-28 2019-10-01 Эгрикалчурал Текнолоджи Рисерч Инститьют Способ получения капсидного белка цирковируса свиней 2 типа и содержащая его фармацевтическая композиция
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
EP3778626A1 (en) * 2016-08-09 2021-02-17 Agricultural Technology Research Institute Composition for preventing and treating mycoplasma hyorhinis infection, and method for producing said composition
JP7082196B2 (ja) * 2017-11-01 2022-06-07 アグリカルチュラル テクノロジー リサーチ インスティテュート マイコプラズマ・シノビエ感染を予防または治療するための組成物
RU2737971C1 (ru) * 2020-05-22 2020-12-07 Эгрикалчурал Текнолоджи Рисерч Инститьют Композиция для профилактики и лечения инфекции mycoplasma hyorhinis и способ получения указанной композиции

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE134705T1 (de) * 1988-06-29 1996-03-15 Ml Technology Ventures Rekombinantes hyopneumoniae antigen und dessen verwendung
EP0571648A1 (en) * 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
CA2113562C (en) * 1992-05-29 2008-06-10 Shuji Saito Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same
DE19816334A1 (de) 1998-04-11 1999-10-14 Krupp Uhde Gmbh Elektrolyseapparat zur Herstellung von Halogengasen
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
ATE412426T2 (de) * 2001-07-02 2008-11-15 Pfizer Prod Inc Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i
US7655413B2 (en) * 2003-06-26 2010-02-02 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
BR0306775A (pt) * 2003-12-23 2005-10-04 Conselho Nacional Cnpq Polinucleotìdeos codificadores de atividades do cromossomo da bactéria mycoplasma hyopneumoniae
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
TW200951219A (en) 2008-05-06 2009-12-16 Academia Sinica An improved SUMO fusion protein system for effective production of native proteins
CA2753121A1 (en) * 2009-02-20 2010-08-26 Cdg Therapeutics, Inc. Compositions and methods to prevent and/or treat cancer with pa-card
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用

Also Published As

Publication number Publication date
KR20150107767A (ko) 2015-09-23
US9750792B2 (en) 2017-09-05
JP2016514086A (ja) 2016-05-19
DK2955192T3 (en) 2020-08-17
US20150366959A1 (en) 2015-12-24
EP2955192B1 (en) 2020-07-01
RU2015137851A (ru) 2017-03-14
CN104918953B (zh) 2019-04-02
UA116431C2 (uk) 2018-03-12
US9750791B2 (en) 2017-09-05
JP6113306B2 (ja) 2017-04-12
MX2015010102A (es) 2016-04-27
US9730990B2 (en) 2017-08-15
KR20170081757A (ko) 2017-07-12
KR101758778B1 (ko) 2017-07-18
EP2955192A4 (en) 2016-11-23
KR101775435B1 (ko) 2017-09-06
BR112015018444A2 (pt) 2018-05-08
US9561267B2 (en) 2017-02-07
KR101831318B1 (ko) 2018-02-22
PH12015501716B1 (en) 2015-11-09
KR20170081760A (ko) 2017-07-12
US20170182144A1 (en) 2017-06-29
US20170202942A1 (en) 2017-07-20
EP2955192A1 (en) 2015-12-16
US20170196959A1 (en) 2017-07-13
KR20170082657A (ko) 2017-07-14
TW201431873A (zh) 2014-08-16
US20170151318A1 (en) 2017-06-01
TWI609878B (zh) 2018-01-01
RU2636459C2 (ru) 2017-11-23
US9775893B2 (en) 2017-10-03
KR101773486B1 (ko) 2017-08-31
CN104918953A (zh) 2015-09-16
US9750790B2 (en) 2017-09-05
MX355078B (es) 2018-04-03
WO2014121433A1 (zh) 2014-08-14
EP3733691A1 (en) 2020-11-04
EP3733690A1 (en) 2020-11-04
US9757441B2 (en) 2017-09-12
KR20170081759A (ko) 2017-07-12
US20170182143A1 (en) 2017-06-29
KR101764750B1 (ko) 2017-08-03
PH12015501716A1 (en) 2015-11-09
KR101838160B1 (ko) 2018-03-13
KR20170081758A (ko) 2017-07-12
US20170182142A1 (en) 2017-06-29
ES2812552T3 (es) 2021-03-17
MX370715B (es) 2019-12-20
KR20170082656A (ko) 2017-07-14
KR101775434B1 (ko) 2017-09-06

Similar Documents

Publication Publication Date Title
UA115348C2 (uk) Композиція для попередження інфекції mycoplasma spp.
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
EA201790532A1 (ru) Способы и композиции для ослабления иммунных ответов против вирусного вектора для переноса
MA46761A (fr) Administration sous-cutanée d'arn messager
UY36006A (es) Construcciones de proteína uspa2 y usos de las mismas.
AR081856A1 (es) Vacuna y metodos para reducir una infeccion por campylobacter
TN2014000518A1 (en) Reassortant btv and ahsv vaccines
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
MX363149B (es) Vacunas de nucleoproteina de la influenza.
PH12015501721A1 (en) Porcine parvovirus 5b, methods of use and vaccine
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
MX2017016401A (es) Composiciones inmunogenas.
WO2015144732A3 (en) Uses of parasite macrophage migration inhibitory factors
MX357431B (es) Vacuna contra garrapatas rhipicephalus.
UY37448A (es) Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus
PH12018500372A1 (en) Fcv recombinant vaccines and uses thereof
MX2016003470A (es) Identificacion de proteinas inmunogenicas para el control de ectoparasitos.
IN2014DE00058A (uk)
MX2021001641A (es) Identificacion de proteinas inmunogenicas para el control de ectoparasitos.
PL412612A1 (pl) Szczep Gram-dodatniej laseczki Bacillus subtillis, rekombinowane przetrwalniki, kompozycja immunogenna, doustna szczepionka oraz jej zastosowanie przeciwko wirusowi grypy typu A
MX2019015700A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015698A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015697A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015696A (es) Vacuna de subunidades anti-mycoplasma spp.